Meros Investment Management LP Sells 253,528 Shares of Embecta Corp. $EMBC

Meros Investment Management LP lowered its stake in shares of Embecta Corp. (NASDAQ:EMBC) by 52.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 231,244 shares of the company’s stock after selling 253,528 shares during the period. Meros Investment Management LP’s holdings in Embecta were worth $2,747,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of EMBC. Royal Bank of Canada increased its stake in shares of Embecta by 38.3% during the 1st quarter. Royal Bank of Canada now owns 18,201 shares of the company’s stock worth $232,000 after purchasing an additional 5,036 shares during the last quarter. AQR Capital Management LLC increased its stake in shares of Embecta by 3.7% during the 1st quarter. AQR Capital Management LLC now owns 225,641 shares of the company’s stock worth $2,738,000 after purchasing an additional 8,109 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Embecta by 2.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 49,323 shares of the company’s stock worth $629,000 after purchasing an additional 1,159 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Embecta by 4.8% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 172,173 shares of the company’s stock worth $2,195,000 after purchasing an additional 7,894 shares during the last quarter. Finally, Jane Street Group LLC increased its stake in shares of Embecta by 224.0% during the 1st quarter. Jane Street Group LLC now owns 132,688 shares of the company’s stock worth $1,692,000 after purchasing an additional 91,729 shares during the last quarter. Hedge funds and other institutional investors own 93.83% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on EMBC. Mizuho decreased their price target on shares of Embecta from $12.00 to $5.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Wall Street Zen lowered shares of Embecta from a “strong-buy” rating to a “hold” rating in a research note on Saturday, May 9th. BTIG Research lowered shares of Embecta from a “buy” rating to a “neutral” rating in a research note on Tuesday, May 5th. Bank of America decreased their price target on shares of Embecta from $11.00 to $3.00 and set an “underperform” rating for the company in a research note on Monday, May 18th. Finally, Weiss Ratings lowered shares of Embecta from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, May 6th. Two research analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Strong Sell” and an average price target of $11.00.

Embecta Trading Up 1.0%

Embecta stock opened at $3.13 on Tuesday. Embecta Corp. has a 1-year low of $2.77 and a 1-year high of $15.55. The firm has a market capitalization of $185.70 million, a price-to-earnings ratio of 1.65 and a beta of 0.84. The firm has a 50 day simple moving average of $5.65 and a 200 day simple moving average of $9.02.

Embecta (NASDAQ:EMBC) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.15). Embecta had a net margin of 10.73% and a negative return on equity of 23.96%. The business had revenue of $221.80 million during the quarter, compared to analysts’ expectations of $235.67 million. During the same quarter in the prior year, the firm posted $0.70 earnings per share. The firm’s quarterly revenue was down 14.4% on a year-over-year basis. Embecta has set its FY 2026 guidance at 1.550-1.75 EPS. On average, equities research analysts forecast that Embecta Corp. will post 1.62 EPS for the current year.

Embecta Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Thursday, May 28th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date was Thursday, May 28th. Embecta’s payout ratio is currently 2.11%.

Embecta Company Profile

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.